APA (7th ed.) Citation

Ogawa, S., Mori, T., Nako, K., & Ito, S. (2008). Combination Therapy with Renin-Angiotensin System Inhibitors and the Calcium Channel Blocker Azelnidipine Decreases Plasma Inflammatory Markers and Urinary Oxidative Stress Markers in Patients with Diabetic Nephropathy. Hypertension research, 31(6), 1147-1155. https://doi.org/10.1291/hypres.31.1147

Chicago Style (17th ed.) Citation

Ogawa, Susumu, Takefumi Mori, Kazuhiro Nako, and Sadayoshi Ito. "Combination Therapy with Renin-Angiotensin System Inhibitors and the Calcium Channel Blocker Azelnidipine Decreases Plasma Inflammatory Markers and Urinary Oxidative Stress Markers in Patients with Diabetic Nephropathy." Hypertension Research 31, no. 6 (2008): 1147-1155. https://doi.org/10.1291/hypres.31.1147.

MLA (9th ed.) Citation

Ogawa, Susumu, et al. "Combination Therapy with Renin-Angiotensin System Inhibitors and the Calcium Channel Blocker Azelnidipine Decreases Plasma Inflammatory Markers and Urinary Oxidative Stress Markers in Patients with Diabetic Nephropathy." Hypertension Research, vol. 31, no. 6, 2008, pp. 1147-1155, https://doi.org/10.1291/hypres.31.1147.